Table 1.
No Chronic Pain (n=14) | Chronic Pain (n=33) | p-value | |
---|---|---|---|
Chronological Age, mean ± SD years | 71.5 ± 7.3 | 70.6 ± 5.5 | 0.647 |
Predicted Brain Age, mean ± SD years | 67.8 ± 10.6 | 69.4 ± 8.6 | 0.592 |
Sex, no. (%) | 0.076* | ||
Male | 6 (52.6) | 6 (18.2) | |
Female | 8 (47.4) | 27 (81.8) | |
Race, no. (%) | 0.304* | ||
Caucasian | 13 (92.9) | 30 (90.9) | |
African American | 0 (0) | 2 (6.1) | |
Asian/Pacific Islander | 1 (7.1) | 0 (0) | |
Other | 0 (0) | 1 (3.0) | |
Education, no. (%) | 0.133* | ||
High school | 2 (14.3) | 11 (33.3) | |
Two-year | 1 (7.1) | 7 (21.2) | |
Four-year | 2 (14.3) | 7 (21.2) | |
Masters | 7 (50.0) | 6 (18.2) | |
Doctorate | 2 (14.3) | 2 (6.1) | |
CES-D, mean ± SD years | 5.9 ± 5.0 | 8.8 ± 5.4 | 0.085* |
3MS, mean ± SD years | 99.1 ± 1.3 | 97.3 ± 3.4 | 0.008* |
Duration of Pain, mean ± SD years | - | 6.3 ± 8.8 | - |
Worst Pain Intensity | - | 5.2 ± 1.9 | - |
# of Anatomical Pain Sites | - | 3.1 ± 2.2 | - |
Medications, no. (%) | 5 (38.5) | 16 (48.5) | 0.421* |
Narcotic Medications (PRN), no. (%) | 0 (0) | 6 (18.2) | 0.088* |
Antidepressant Medications, no. (%) | 1 (7.1) | 9 (27.3) | 0.123* |
Anticonvulsant Medications, no. (%) | 0 (0) | 4 (12.1) | 0.173* |
NSAID Medications, no. (%) | 4 (28.6) | 16 (48.5) | 0.207* |
X2